Attention and craving. Advances in its conceptualization and its implications for relapse prevention;Atención y craving o ganas compulsivas. Avances en su conceptualización y su implicación en la prevención de recaídas

Adicciones

Volumn 20, Issue 4, 2008, Pages 365-376

  Blasco Gallego, Jesús ^a,e   Martínez Raga, José ^a,b   Carrasco, Emelia ^c   Didia Attas, Javier ^d  

^a Unidad de Conductas Adictivas   (Spain)

^b UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^c Hospital Italiano de Buenos Aires ^*

^d HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^e Centro de Salud de Corea   (Spain)

Author keywords

Attention; Craving; Mindfulness; Relapse prevention; Selective attention

Indexed keywords

ALCOHOL ABUSE; ATTENTION; COGNITION; HUMAN; REVIEW; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME; COGNITIVE THERAPY; IMPULSE CONTROL DISORDER; METHODOLOGY; RECURRENT DISEASE;

ATTENTION; COGNITIVE THERAPY; HUMANS; IMPULSE CONTROL DISORDERS; RECURRENCE;

EID: 58149229404     PISSN: 02144840     EISSN: None     Source Type: Journal    
DOI: 10.20882/adicciones.259     Document Type: Review

References (120)

1. Kozlowski LT, Wilkinson A. Use and misuse of the concept of craving by alcohol, tobacco, and drug researchers. Br J Addict 1987; 82: 31-6.
2. Organización Mundial de la Salud. Décima revisión de la Clasificación Internacional de Enfermedades (CIE-10). Trastornos Mentales y del Comportamiento. Descripciones Clínicas y Pautas para el Diagnóstico. Madrid: Ed Meditor; 1992.
3. Grace A. The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction 2000; 95 Supl 2: 119-28.
4. Koob G, Le Moal M. Drug abuse: Hedonic homeostatic dysregulation. Science 1997; 278: 52-8.
5. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 1993; 18: 247-91.
6. Lowman C, Hunt W, Litten R, Drummond C. Research perspectives on alcohol craving: an overview. Addiction 2000; 95 Supl 2: 45-54.
7. Littleton J. Can craving be modelled in animals? The relapse prevention perspective. Addiction 2000; 95 Supl 2: 83-90.
8. Larimer ME, Palmer RS, Marlatt A. Relapse prevention. An overview of Marlatt's cognitive-behavioral model. Alcohol Res Health 1999; 23: 151-60.
9. Niaura R. Cognitive social learning and related perspectives on drug craving. Addiction 2000; 95 Supl 2: 155-63.
10. Baker T, Morse E, Sherman J. The motivation to use drugs: A psychobiological analysis of urges. The Nebraska Symposium on Motivation: Alcohol Use and Abuse. Lincoln. NE: University of Nebraska Press; 1987. p. 257-323.
11. May J, Andrade J, Panabokke N, Kavanagh D. Images of desire: cognitive models of craving. Memory 2004; 12: 447-61.
12. Tiffany ST, Conklin CA. A cognitive processing model of alcohol craving and compulsive alcohol use. Addiction 2000; 95 Supl 2: 145-53.
13. Marlatt GA, Gordon JR, editores. Relapse prevention: Maintenance strategies in addictive behavior change. New York: Guildford; 1985.
14. Litman G, Stapleton J, Rawson N, Oppenheimer A, Peleg M, Jackson P. Situations related to alcoholism relapse. Br. J Addict 1983; 78: 381-9.
15. Merikle EP. The subjective experience of craving: an exploratory analysis. Subst Use Misuse 1999; 34: 1101-5.
16. Tiffany ST. A cognitive model of drug urges and drug-use behavior: Role of automatic and non-automatic processes. Psychol Rev 1990; 97: 147-68.
17. Tiffany ST. The role of cognitive factors in reactivity to drug cues. En: Drummond DC, Tiffany ST, Glautier SP, Remington B, editores. Addictive Behavior: Cue Exposure Theory and Practice. Chichester, England: John Wiley; 1995. p. 137-65.
18. Ramos J, Tejero A, Trujols J. ¿Craving como elemento central o como epifenómeno en las conductas adictivas? Una revisión de la propuesta de Tiffany. Adicciones 1998; 10: 217-21.
19. Boring EG. A History of Experimental Psychology. New York: Appleton-Century Crofts; 1950.
20. Broadbent DE. Perception and Communication. London: Pergamon Press; 1958.
21. Kahneman D. Attention and Effort. Englewood Cliffts: Prentice-Hall; 1973.
22. Phaf RH, Van der Heijden AH, Hudson PT. SLAM: A connectionist model for attention in visual selection tasks. Cognit Psychol 1990; 22: 273-341.
23. Raz A, Buhle J. Typologies of attentional networks. Nat Rev Neurosci 2006; 7: 367-79.
24. Allport DA. Selection for attention: Some behavioral and neurophysiological considerations on attention and action. En: Heuer H, Sanders AF, editores. Issues on Perception and Action. Hillsdale, NJ: Erlbaum; 1987. p. 395-420.
25. Estevez-Gonzalez A, Garcia-Sanchez C, Junque C. Atención: una función cerebral compleja. Rev Neurol 1997; 25: 1989-97.
26. James W. The Principles of Psychology. New York: Dover; 1890.
27. Pashler HE. The Psychology of Attention. Cambridge, MA: The MIT Press; 1997.
28. Posner MI. Attention: the mechanisms of consciousness. Proc Natl Acad Sci USA 1994; 91: 7398-403.
29. Van der Heijden AH, Bern S. Successive approximations to an adequate model of attention. Conscious Cogn 1997; 6: 413-28.
30. Parasuraman R, Davies DR, editores. Varieties of Attention. Orlando: Academic Press; 1984.
31. Baars BJ. Some essential differences between consciousness and attention, perception, and working memory. Conscious Cogn 1997; 6: 363-71.
32. Norman DA, Shallice T. Attention to action. Willed and automatic control of behavior. En: Davison RJ, Schwartz GE, Shapiro D, editores. Consciouness and Self-regulation (Vol. 4). New York: Plenum Press; 1986. p. 1-18.
33. Reason J. Lapses of attention in everyday life. En: Parasuraman R, Davies DR editores. Varieties of Attention. New York: Academic Press; 1984. p. 515-50.
34. LaBerge D. Attentional control: brief and prolonged. Psychol Res 2002; 66: 220-33.
35. Johnston WA, Dark VJ. Selective attention. Ann Rev Psychol 1986; 37: 43-75.
36. Logan GD. Attention, automaticy and the ability to stop a speeded choice response. En: Long J, Baddeley A, editores. Attention and performance, IX. Hillsdale, NJ: Erlbaum; 1981. p. 205-22.
37. Courtney SM. Attention and cognitive control as emergent properties of information representation in working memory. Cogn Affect Behav Neurosci 2004; 4: 501-16.
38. Szymura B, Neka E. Visual selective attention and personality: An experimental verification of three models of extraversion. Pers Individ Dif 1998; 25: 713-29.
39. Posner MI, Rothbart MK. Attention, self-regulation and consciousness. Philos Trans R Soc Lond B Biol Sci 1998; 353: 1915-27.
40. Marcel AJ. Conscious and unconscious perception: Experiments on visual masking and word recognition. Cognit Psychol 1983; 15: 197-237.
41. Myers GL, Fisk AD. Training consistent task components: application of automatic and controlled processing theory to industrial task training. Hum Factors 1987; 29: 255-68.
42. Vecera SP, Rizzo M. Spatial attention: normal processes and their breakdown. Neurol Clin 2003; 21: 575-607
43. Bargh JA, Ferguson MJ. Beyond behaviorism: on the automaticity of higher mental processes. Psychol Bull 2000; 126: 925-45.
44. Schneider W, Pimm-Smith M, Worden M. Neurobiology of attention and automaticity. Curr Opin Neurobiol 1994; 4: 177-82.
45. Naveh-Benjamin M. Coding of spatial location information: An automatic process? J Exp Psychol Learn Mem Cogn 1987; 13: 595-605.
46. Zbrodroff NJ, Logan CD. On the autonomy of mental processes: A case study of arithmetic. J Exp Psychol Gen 1986; 115: 118-30.
47. Duncan J. Consistent and varied training in the theory of automatic and controlled informacion processing. Cognition 1986; 23: 279-84.
48. Schneider W, Fisk AD. Automatic category search and its transfer. J Exp Psychol Learn Mem Cogn 1984; 10: 1-15.
49. Shiffrin RM, Dumais ST. The development of automatism. En: Anderson JR, editor. Cognitive skills and their acquisition. Hillsdale, NJ: Erlbaum; 1981. p. 111-40.
50. Houghton G, Tipper SP. Inhibitory mechanisms of neural and cognitive control: applications to selective attention and sequential action. Brain Cogn 1996; 30: 20-43.
51. Tipper SP, Cranston M. Selective attention and priming: inhibitory and facilitatory effects of ignored primes. Q J Exp Psychol A 1985; 37: 591-611.
52. Wanigaratne S. Psychology of addiction. Psychiatry 2006; 5: 455-60.
53. Witkiewitz K, Marlatt GA. Relapse prevention for alcohol and drug problems: that was Zen, this is Tao. Am Psychol 2004; 59: 224-35.
54. Brownell KD, Marlatt GA, Lichtenstein E, Wilson GT. Understanding and preventing relapse. Am Psychol 1986; 41: 765-82.
55. Marlatt GA, Witkiewitz K. Relapse prevention for alcohol and drug problems. En: Marlatt GA, Donovan DM, editores. Relapse Prevention, Second edition, Maintenance Strategies in the Treatment of Addictive Behaviors. New York: The Guildford Press; 2005. p. 1-44.
56. Marlatt GA. Alcohol, the magic elixir: Stress, expectancy, and the transformation of emotional states. En: Gottheil E, Druly KA, Pashko S, Weinstein SP, editores. Stress and Addiction. New York: Brunner/Mazel; 1987. p. 302-22.
57. Ryan F. Detected, selected, and sometimes neglected: Cognitive processing of cues in addiction. Exp Clin Psychopharmacol 2002; 10: 67-76.
58. Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat 2005; 28: 321-9.
59. Fiellin DA, Pantalon MV, Chawarski MC, Moore BA, Sullivan LE, O'Connor PG, et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med 2006; 355: 365-74.
60. van den Brink W, Haasen C. Evidenced-based treatment of opioid-dependent patients. Can J Psychiatry 2006; 51: 635-46.
61. Kirchmayer U, Davoli M, Verster A. Naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev 2006; CD001333.
62. Sofuoglu M, Kosten TR. Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin Emerg Drugs 2006; 11: 91-8.
63. Vocci FJ, Acri J, Elkashef A. Medication development for addictive disorders: The state of the science. Am J Psychiatry 2005; 162: 1432-40.
64. Martinez Raga J, Knecht C, Cepeda S. Modafinil: A useful medication for cocaine addiction? Review of the evidence from neuropharmacological, experimental and clinical studies. CDAR 2008; 1: 213-21.
65. West SL. Pharmacological treatment of alcohol dependence. JAMA 1999; 281: 1318-25.
66. Kleber HD, Weiss RD, Anton RF Jr, George TP, Greenfield SF, Kosten TR, et al. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry 2007; 164 Supl 4: 5-123.
67. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2007; CD006103.
68. Lancaster T, Stead L, Cahill K. An update on therapeutics for tobacco dependence. Expert Opin Pharmacother 2008; 9: 15-22.
69. Timko C, Finney JW, Moos RH. The 8-year course of alcohol abuse: gender differences in social context and coping. Alcohol Clin Exp Res 2005; 29: 612-21.
70. Cutler RB, Fishbain DA. Are alcoholism treatments effective? The Project MATCH data. BMC Public Health 2005; 5: 75.
71. Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008; 165: 179-87.
72. Irvin JE, Bowers CA, Dunn ME, Wang MC. Efficacy of relapse prevention: A meta-analytic review. J Consult Clin Psychol 1999; 67: 563-70.
73. Roll JM. Contingency management: an evidence-based component of methamphetamine use disorder treatments. Addiction 2007; 102 Supl 1: 114-20.
74. Schottenfeld RS, Chawarski MC, Pakes JR, Pantalon MV, Carroll KM, Kosten TR. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. Am J Psychiatry 2005; 162: 340-9.
75. McKay JR, Alterman AI, Cacciola JS, Rutherford MJ, O'Brien CP, Koppenhaver J. Group counseling versus individualizad relapse prevention aftercare following intensive outpatient treatment for cocaine dependence: initial results. J Consult Clin Psychol 1997; 65: 778-88.
76. Rohsenow DJ, Monti PM, Martin RA, Michalec E, Abrams DB. Brief coping skills treatment for cocaine abuse: 12-month substance use outcomes. J Consult Clin Psychol 2000; 68: 515-20.
77. Higgins ST, Wong CJ, Badger GJ, Haug Ogden DE, Dantona RL. Contingent reinforcement increases abstinence during outpatient treatment and 1 year of follow-up. J Consult Clin Psychol 2000; 68: 64-72.
78. Silverman K, Chutuape MA, Bigelow GE, Stitzer ML. Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude. Psychopharmacology 1999; 146: 128-38.
79. Guichenez P, Clauzel I, Cungi C, Quantin X, Godard P, Clauzel AM. The contribution of cognitive behavioural therapies to smoking cessation. Rev Mal Respir. 2007; 24: 171-82.
80. Holder HD, Cisler RA, Longabaugh R, Stout RL, Treno AJ, Zweben A. Alcoholism treatment and medical care costs from Project MATCH. Addiction 2000; 95: 999-1013.
81. Irvin JE, Bowers CA, Dunn ME, Wang MC. Efficacy of relapse prevention: A meta-analytic review. J Consult Clin Psychol 1999; 67: 563-70.
82. Carroll KM, Rounsaville BJ, Gordon LT, Nich C, Jatlow PM, Bisighini RM, et al. Psychotherapy and pharmacotherapy for cocaine abusers. Arch Gen Psychiatry 1994; 51: 177-87.
83. Maude-Griffin PM, Hohenstein JM, Humfleet GL, Reilly PM, Tusel DJ, Hall SM. Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: main and matching effects. J Consult Clin Psychol 1998; 66: 832-37.
84. Hawkins JD, Catalano RF Jr, Gillmore MR, Wells EA. Skills training for drug abusers: generalization, maintenance, and effects on drug use. J Consult Clin Psychol 1989; 57: 559-63.
85. Woody GE, McLellan AT, Luborsky L, O'Brien CP. Twelve-month follow-up of psychotherapy for opiate dependence. Am J Psychiatry 1987; 144: 590-6.
86. Baer RA. Mindfulness training as a clinical intervention: a conceptual and empirical review. Clin Psychol 2003; 10: 125-43.
87. Krisanaprakornkit T, Krisanaprakornkit W, Piyavhatkul N, Laopaiboon M. Meditation therapy for anxiety disorders. Cochrane Database Syst Rev 2006; CD004998.
88. Allen NB, Chambers R, Knight W, Melbourne Academic Mindfulness Interest Group. Mindfulness-based psychotherapies: a review of conceptual foundations, empirical evidence and practical considerations. Aust N Z J Psychiatry 2006; 40: 285-94.
89. Bishop SR, Lau M, Shapiro S, Carlson L, Anderson ND, Carmody J, et al. Mindfulness: A proposed operational definition. Clin Psychol 2004; 11: 230-41.
90. Kabat-Zinn J. Mindfulness-based interventions in context: past, present, and future. Clin Psychol 2003; 10: 144-56.
91. Leigh J, Bowen S, Marlatt GA. Spirituality, mindfulness and substance abuse. Addict Behav 2005; 30: 1335-41.
92. Kabat-Zinn J. Wherever you go, there you are: mindfulness meditation in everyday life. New York: Hyperion; 1994.
93. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 2000; 68: 615-23.
94. Witkiewitz K, Marlatt GA, Walter D. Mindfulness-based relapse prevention for alcohol and substance use disorders. J Cogn Psychother 2005; 19: 211-28.
95. Curtis F, Zack M, McMain S. An information-processing analysis of mindfulness: implications for relapse prevention in the treatment of substance abuse. Clin Psychol Sci Prac 2002; 9: 275-99.
96. Kabat-Zinn J, Massion AO, Kristeller J, Peterson L, Fletcher KE, Pbert L. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am J Psychiatry 1992; 149: 936-43.
97. Grossman P, Niemann L, Schmidt S, Walach H. Mindfulness-based stress reduction and health benefits. A meta-analysis. J Psychosom Res 2004; 57: 35-43.
98. Linehan M. Cognitive-behavioral treatment of borderline personality disorder. New York: Guildford Press; 1993.
99. Segal ZV, Williams JMG, Teadsle J. Mindfulness-based cognitive therapy for depression: a new approach to preventing relapse. New York: Guildford, 2002.
100. Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy. New York: Guildford Press; 1999.
101. Buccheld N, Grossman P, Walach H. Measuring mindfulness in insight meditation (Vipassana) and meditation-based psychotherapy: The development of the Freiburg Mindfulness Inventory (FMI). J Medit Medit Res 2001; 1: 11-34.
102. Brown KW, Ryan RM. The benefits of being present: Mindfulness and its role in psychological well-being. J Pers Soc Psychol 2003; 84: 822-48.
103. Baer RA, Smith GT, Allen KB. Assessment of mindfulness by self-report: The Kentucky Inventory of Mindfulness Skills. Assessment 2004; 11: 191-206.
104. th Annual Convention of the Association for Behavioral and Cognitive Therapies. 2005. Washington, DC, Noviembre de 2005.
105. Cardaciotto L, Herbert JD. The development of a bi-dimensional measure of mindfulness: The Philadelphia Mindfulness Scale (PHLMS). Comunicación presentada a la 39th Annual Convention of the Association of Behavioral and Cognitive Therapies. 2005. Washington, DC, Noviembre de 2005.
106. Lau MA, Bishop SR, Segal ZV, Buis T, Anderson ND, Carlson L, et al. The Toronto Mindfulness Scale: development and validation. J Clin Psychol 2006; 62: 1445-67.
107. Alterman AI, Koppenhaver JM, Mulholland E, Ladden LJ, Baime MJ. Pilot trial of effectiveness of mindfulness meditation for substance abuse patients. J Subst Use 2004; 9: 259-68.
108. Bowen S, Witkiewitz K, Dillworth TM, Charla N, Simpson TL, Ostafin BD, et al. Mindfulness meditation and substance use in an incarcerated population. Psychol Addict Behav 2006; 20: 343-7.
109. Davis JM, Fleming MF, Bonus KA, Baker TB. A pilot study on mindfulness based stress reduction for smokers. BMC Complement Altern Med 2007; 7: 2.
110. Bowen S, Witkiewitz K, Dillworth TM, Marlatt GA. The role of thought suppression in the relationship between mindfulness meditation and alcohol use. Addict Behav 2007; 32: 2324-8.
111. Shafil M, Lavely R, Jaffe R. Meditation and the prevention of alcohol abuse. Am J Psychiatry 1975; 132: 942-5.
112. Jha AP, Krompinger J, Baime MJ. Mindfulness training modifies subsystems of attention. Cogn Affect Behav Neurosci 2007; 7: 109-19.
113. Garcia R, Monterrey AL, Gonzalez de Rivera JR. Meditación y psicosis. Psiquis 1992; 13: 39-43.
114. Walsh R, Roche L. Precipitation of acute psychotic episodes by intensive meditation in individuals with a history of schizophrenia. Am J Psychiatry 1979; 136: 1085-6.
115. Sethi S, Bhargava SC. Relationship of meditation and psychosis: case studies. Aust N Z J Psychiatry 2003; 37: 382.
116. Chan-OBT, Boonyanaruthee V. Meditation in association with psychosis. J Med Assoc Thai 1999; 82: 925-30.
117. Otis SL. The facts on transcendental meditation: III. If well-integrated but anxious, try MT. Psychol Today 1974; 7: 45-6.
118. Lazarus AA. Psychiatric problems precipitated by Transcendental Meditation. Psychol Rep 1976; 39: 601-2.
119. Simpson TL, Kaysen D, Bowen S, MacPherson LM, Chawla N, Blume A, et al. PTSD symptoms, substance use, and vipassana meditation among incarcerated individuals. J Trauma Stress 2007; 20: 239-49.
120. Zylowska L, Ackerman DL, Yang MH, Futrell JL, Horton NL, Hale TS, et al. Mindfulness meditation training in adults and adolescents with ADHD: A feasibility study. J Atten Disord 2008; 11: 737-46.